UBS analyst Kevin Caliendo adjusted the price target for CVS Health (NYSE:CVS) shares, bringing it down to $59.00 from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback